Arcus Biosciences, Inc. (RCUS)

Import this data to Google Sheets with:

=jivedata("RCUS","financials")

Full statements spill as a table. For one cell: =jivedata("RCUS","Revenue") or =jivedata("RCUS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Arcus Biosciences, Inc.

RCUS • CIK 0001724521

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-340,000	$-330,000	$-386,000	$-486,000
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-301,000	$-282,000	$-353,000	$-460,000
Income Tax Expense (Benefit)	$6,000	$1,000	$0	$0
Net Income (Loss) Attributable to Parent	$-307,000	$-283,000	$-353,000	$-460,000
Weighted Average Number of Shares Outstanding, Basic	74,000,000	90,100,000	107,400,000	130,800,000
Revenues	—	$258,000	$247,000	$117,000
Research and Development Expense	$340,000	$448,000	$523,000	$497,000
General and Administrative Expense	$117,000	$120,000	$110,000	$106,000
Operating Lease, Impairment Loss	—	$20,000	$0	$0
Operating Expenses	$457,000	$588,000	$633,000	$603,000
InterestExpenseNonoperating	—	$4,000	$8,000	$11,000
Nonoperating Income (Expense)	$39,000	$48,000	$33,000	$26,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$127,000	$150,000	$222,000	$150,000
Debt Securities, Available-for-sale, Current	$632,000	$828,000	$759,000	$552,000
Debt Securities, Available-for-sale, Noncurrent	$107,000	$14,000	$29,000	$73,000
Contract with Customer, Asset, after Allowance for Credit Loss, Current	$38,000	$20,000	$11,000	$36,000
Property, Plant and Equipment, Net	$51,000	$47,000	$40,000	$36,000
Prepaid Expense and Other Assets, Current	$34,000	$18,000	$15,000	$18,000
Other Assets, Noncurrent	$106,000	$73,000	$63,000	$59,000
Assets, Current	$831,000	$1,016,000	$1,007,000	$756,000
Assets	$1,095,000	$1,150,000	$1,139,000	$924,000
Contract with Customer, Liability, Noncurrent	$307,000	$234,000	$43,000	$37,000
Long-term Debt	—	$48,000	$99,000	$101,000
Other Liabilities, Noncurrent	$142,000	$157,000	$135,000	$124,000
Common Stock, Value, Issued	$1,311,000	$1,617,000	$2,116,000	$2,169,000
Retained Earnings (Accumulated Deficit)	$-849,000	$-1,132,000	$-1,485,000	$-1,704,000
Stockholders' Equity Attributable to Parent	$462,000	$485,000	$631,000	$464,000
Accounts Payable, Current	$17,000	$18,000	$42,000	$34,000
Contract with Customer, Liability, Current	$91,000	$85,000	$35,000	$19,000
Other Liabilities, Current	$76,000	$123,000	$154,000	$145,000
Liabilities, Current	$184,000	$226,000	$231,000	$198,000
Common Stock, Shares Authorized	400,000,000	400,000,000	400,000,000	400,000,000
Common Stock, Shares, Issued	75,500,000	92,200,000	125,300,000	127,000,000
Interest Receivable, Current	$4,000	$5,000	$5,000	$5,000
Employee-related Liabilities, Current	$26,000	$31,000	$33,000	$21,000
Taxes Payable, Current	—	$1,000	$1,000	$1,000
Operating Lease, Liability, Current	$11,000	$12,000	$13,000	$13,000
Other Sundry Liabilities, Current	$3,000	$14,000	$18,000	$12,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-307,000	$-283,000	$-353,000	$-460,000
Net Cash Provided by (Used in) Operating Activities	$-306,000	$-170,000	$-482,000	$-474,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-79,000	$23,000	$72,000	$-98,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$130,000	$153,000	$225,000	$234,000
Share-based Payment Arrangement, Noncash Expense	$73,000	$76,000	$60,000	$63,000
Payments to Acquire Marketable Securities	$788,000	$1,043,000	$1,076,000	$894,000
Depreciation, Depletion and Amortization, Nonproduction	$8,000	$10,000	$10,000	$10,000
Operating Lease, Right-of-Use Asset, Amortization Expense	$8,000	$7,000	$7,000	$8,000
Operating Lease, Impairment Loss	—	$20,000	$0	$0
Payments to Acquire Property, Plant, and Equipment	$24,000	$6,000	$2,000	$1,000
Accretion (Amortization) of Discounts and Premiums, Investments	$19,000	$25,000	$13,000	$11,000
Net Cash Provided by (Used in) Investing Activities	$194,000	$-84,000	$66,000	$63,000
Other Operating Activities, Cash Flow Statement	$2,000	$3,000	$1,000	$3,000
Proceeds from Issuance of Common Stock	$25,000	$228,000	$429,000	$287,000
Proceeds from Issuance of Debt	—	$47,000	$49,000	$0
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$8,000	$9,000	$10,000	$26,000
Payment, Tax Withholding, Share-based Payment Arrangement	—	$7,000	$0	$0
Net Cash Provided by (Used in) Financing Activities	$33,000	$277,000	$488,000	$313,000
Income Taxes Paid	$5,000	$0	$0	$0
Interest Paid, Excluding Capitalized Interest, Operating Activities	—	$1,000	$7,000	$7,000
Capital Expenditures Incurred but Not yet Paid	$2,000	$0	$0	$0
Increase (Decrease) in Contract with Customer, Asset	$-15,000	$-28,000	$-9,000	$-9,000
Increase (Decrease) in Other Noncurrent Assets	$14,000	$-22,000	$-5,000	$-3,000
Increase (Decrease) in Accounts Payable	$-1,000	$3,000	$24,000	$5,000
Increase (Decrease) in Contract with Customer, Liability	$-68,000	$-56,000	$-240,000	$-106,000
Increase (Decrease) in Other Noncurrent Liabilities	$-3,000	$25,000	$8,000	$2,000

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("RCUS","financials")

Full statements spill as a table. For one cell: =jivedata("RCUS","Revenue") or =jivedata("RCUS","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.